M. Memoli

M. Eichelberger, J. Taubenberger, M. Memoli, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mosquito Saliva: The Hope for a Universal Arbovirus Vaccine?

D. Morens, S. Kamhawi, J. Valenzuela, 2018, The Journal of infectious diseases.

Bizionia argentinensis sp. nov., isolated from surface marine water in Antarctica.

S. Vázquez, S. Coria, P. Yankilevich, 2008, International journal of systematic and evolutionary microbiology.

Critically ill patients with H7N9: new virus, old challenges*.

M. Memoli, Matthew J. Memoli, 2015, Critical care medicine.

Pandemic research in the ICU: always be prepared.

M. Memoli, 2013, Critical care medicine.

A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy Adults

D. Bernstein, P. Roberts, W. Keitel, 2022, medRxiv.

Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial

O. Pleguezuelos, G. Stoloff, S. Kamhawi, 2020, The Lancet.

Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial

O. Pleguezuelos, G. Stoloff, S. Kamhawi, 2022, eBioMedicine.

SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia

J. Taubenberger, Chanthap Lon, P. Duffy, 2022, Emerging infectious diseases.

Pre-pandemic SARS-CoV-2 serological reactivity in rural malaria-experienced Cambodians

J. Taubenberger, P. Duffy, Sokunthea Sreng, 2021, medRxiv.

Detection of seasonal H3N2 influenza A virus by type-specific TaqMan minor groove binder probe assay.

J. Taubenberger, L. M. Schwartzman, Ruixue Wang, 2011, Diagnostic microbiology and infectious disease.

Ethics of controlled human infection to address COVID-19

Seema K. Shah, M. Selgelid, H. Lynch, 2020, Science.

Responding to the COVID-19 pandemic: Ethical considerations for conducting controlled human infection studies

Seema K. Shah, Saxena, Abha, 2020 .

Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

M. Fay, D. Esposito, M. Hall, 2021, Nature communications.

Proinflammatory IgG Fc structures in patients with severe COVID-19

Shenmin Zhang, J. Andrews, J. Taubenberger, 2020, Nature Immunology.

Symptomatic SARS-CoV-2 infections display specific IgG Fc structures.

Shenmin Zhang, J. Andrews, J. Taubenberger, 2020, medRxiv : the preprint server for health sciences.

Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study

J. Taubenberger, O. Pleguezuelos, G. Stoloff, 2020, npj Vaccines.

Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.

K. Walters, J. Taubenberger, D. Morens, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.

J. Taubenberger, M. Memoli, A. Han, 2019, Virology.

Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19

W. Travis, K. Walters, J. Taubenberger, 2021, Science Translational Medicine.

Influenza in pregnancy

M. Memoli, Jeffery K. Taubenberger, David M. Morens, 2012, Influenza and other respiratory viruses.

IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

J. Taubenberger, J. Wrammert, R. Ahmed, 2017, Science.

Bacterial coinfection in influenza: a grand rounds review.

Daniel S. Chertow, D. Chertow, M. Memoli, 2013, JAMA.

Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

M. Fay, D. Esposito, M. Hall, 2020, medRxiv.

An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice.

J. Taubenberger, T. Tumpey, Z. Sheng, 2009, Virology.

Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease

J. Dye, K. Walters, D. Baxter, 2017, Science Translational Medicine.

Pandemic and seasonal influenza: therapeutic challenges.

J. Taubenberger, D. Morens, M. Memoli, 2008, Drug discovery today.

The 1918 influenza pandemic: Lessons for 2009 and the future

J. Taubenberger, D. Morens, M. Memoli, 2010, Critical care medicine.

Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets.

Daniel S. Chertow, J. Taubenberger, A. Davis, 2011, The Journal of infectious diseases.

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies

M. Eichelberger, D. Burke, J. Taubenberger, 2019, mBio.

D614G Spike Variant Does Not Alter IgG, IgM, or IgA Spike Seroassay Performance

M. Hall, J. Mehalko, K. Sadtler, 2020, medRxiv.

The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts

J. Taubenberger, R. Hagey, S. Shoham, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

S. Reis, M. Fay, D. Esposito, 2021, Science Translational Medicine.

Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States

S. Reis, M. Fay, D. Esposito, 2021, medRxiv.

Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

M. Fay, M. Hall, A. Shunmugavel, 2021, Nature Communications.

Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine

J. Taubenberger, D. Morens, M. Memoli, 2020, Vaccines.

The PB 2E 627 K Mutation Attenuates Viruses Containing the 2009 H 1 N 1 Influenza Pandemic Polymerase

G. L. Allen, P. Digard, Ruixue Wang, 2017 .

pH1N1 influenza A: timing is everything.

M. Memoli, 2010, Critical care medicine.

Mechanisms of Transplacental Transmission of HIV-1: I. Infection of Fetal Placental Layers in the Intervillous Spaces

O. Bagasra, D. Patel, P. Saikumari, 1999 .

Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift.

J. Taubenberger, Vivien G. Dugan, M. Memoli, 2009, The Journal of infectious diseases.

Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model.

J. Taubenberger, J. Sadoff, S. Hunsberger, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model

N. Leidy, J. Powers, J. Poon, 2018, BMC Infectious Diseases.

Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus

J. Taubenberger, M. Memoli, A. Han, 2018, mBio.

Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.

R. Davey, J. Taubenberger, P. Shaw, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients.

P. Danaher, N. Leidy, J. Powers, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

In vivo evaluation of pathogenicity and transmissibility of influenza A(H1N1)pdm09 hemagglutinin receptor binding domain 222 intrahost variants isolated from a single immunocompromised patient.

Eleca J. Dunham, J. Taubenberger, A. Davis, 2012, Virology.

The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine

K. Walters, J. Taubenberger, K. Scherler, 2021, NPJ vaccines.